711 filings
Page 15 of 36
SC 13G
i9or4hcl0xbg pou1
5 Feb 21
KEMPHARM / Auctus Fund ownership change
2:04pm
S-8
lydyp
4 Feb 21
Registration of securities for employees
5:27pm
D
k9tjj00arrzj mld6h8t
4 Feb 21
$44.03M in options / securities to be acquired, sold $44.03M, 15 investors
4:18pm
424B3
eqzo816afl cfwll5p
27 Jan 21
Prospectus supplement
9:22am
8-K
xnuwiv54hf7r3b 2kl
27 Jan 21
KemPharm Receives FDA Clearance to Initiate KP879 Clinical Program for the Treatment of Stimulant Use Disorder
9:17am
424B3
o79x7
26 Jan 21
Prospectus supplement
5:02pm
8-K
t8eblphpw z42x3l
26 Jan 21
Entry into a Material Definitive Agreement
9:16am
EFFECT
91y1 kbny
25 Jan 21
Notice of effectiveness
12:19am
424B5
ffl22wo2twso7wze
22 Jan 21
Prospectus supplement for primary offering
5:24pm
CORRESP
biw0wul7hktau
20 Jan 21
Correspondence with SEC
12:00am
UPLOAD
5hb98hp33
19 Jan 21
Letter from SEC
12:00am
SC 13G
9i0neis bu
14 Jan 21
KEMPHARM / Empery Asset Management ownership change
9:00am
D
1hx4rd
13 Jan 21
$31.48M in equity / options / securities to be acquired, sold $31.48M, 4 investors
4:15pm
8-K
7v4jua3nq
13 Jan 21
KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
12:00am
424B4
gck2uooc m2tq
8 Jan 21
Prospectus supplement with pricing info
9:38pm
EFFECT
oflznykc3uxq9f9
8 Jan 21
Notice of effectiveness
12:15am
POS EX
olfe77rx fpq0wcpzcy1
8 Jan 21
Additional exhibits for listing
12:00am
S-1MEF
zhzfnm 10idey
7 Jan 21
Registration of additional securities for an S-1
6:11pm
CERT
ouwwa
7 Jan 21
Certification of approval for exchange listing
9:54am